Detalhe da pesquisa
1.
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 68(4): e0108123, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376189
2.
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.
Antimicrob Agents Chemother
; 67(1): e0131222, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622154
3.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Antimicrob Agents Chemother
; 67(8): e0041423, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428034
4.
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
J Antimicrob Chemother
; 78(6): 1460-1470, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071586
5.
Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach.
Mol Pharm
; 20(3): 1509-1518, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512679
6.
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Antimicrob Agents Chemother
; 66(3): e0220321, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041509
7.
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Antimicrob Agents Chemother
; 66(10): e0059122, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125299
8.
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
J Antimicrob Chemother
; 77(7): 1923-1930, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470370
9.
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782000
10.
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366710
11.
Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
Clin Infect Dis
; 69(11): 1962-1968, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30722017
12.
Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Antimicrob Agents Chemother
; 63(11)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427301
13.
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636062
14.
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745381
15.
16.
Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.
Adv Exp Med Biol
; 1145: 219-249, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364081
17.
Labelling Conventions and Product Package Insert of Parenteral Polymyxins: Factors Causing Potential Medication Errors and Impeding Optimal Clinical Use.
Adv Exp Med Biol
; 1145: 133-141, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364076
18.
Mechanisms of Polymyxin-Induced Nephrotoxicity.
Adv Exp Med Biol
; 1145: 305-319, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364084
19.
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760144
20.
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses".
Antimicrob Agents Chemother
; 67(2): e0168522, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656004